Search Page

1

Cite

Share

Integrative structural modeling of a multidomain polo-like kinase.

Ruan H , Kiselar J , Zhang W , Li S , Xiong R , Liu Y , Yang S , Lai L . Ruan H , et al. Among authors: li s. Phys Chem Chem Phys. 2020 Dec 16;22(47):27581-27589. doi: 10.1039/d0cp05030j. Phys Chem Chem Phys. 2020. PMID: 33236741

Cite

Share

2

Cite

Share

Impact of Glycosylation on the Comparability of the Higher-Order Structures in Idursulfase by Hydrogen-Deuterium Exchange Mass Spectrometry.

Barton C, Li XS, Li SP, Flaherty B, Sison L, Lu Q, Yeung B, Wu SL. Barton C, et al. Among authors: li sp. Anal Chem. 2020 Jun 16;92(12):8306-8314. doi: 10.1021/acs.analchem.0c00661. Epub 2020 Jun 2. Anal Chem. 2020. PMID: 32420732

Cite

Share

3

Cite

Share

Upregulation of DPY30 promotes cell proliferation and predicts a poor prognosis in cholangiocarcinoma.

Hong ZF, Zhang WQ, Wang SJ, Li SY, Shang J, Liu F, Shen DY. Hong ZF, et al. Biomed Pharmacother. 2020 Mar;123:109766. doi: 10.1016/j.biopha.2019.109766. Epub 2019 Dec 14. Biomed Pharmacother. 2020. PMID: 31846841 Free article.

Cite

Share

4

Cite

Share

Mutations in fbiD (Rv2983) as a Novel Determinant of Resistance to Pretomanid and Delamanid in Mycobacterium tuberculosis.

Rifat D, Li SY, Ioerger T, Shah K, Lanoix JP, Lee J, Bashiri G, Sacchettini J, Nuermberger E. Rifat D, et al. Antimicrob Agents Chemother. 2020 Dec 16;65(1):e01948-20. doi: 10.1128/AAC.01948-20. Print 2020 Dec 16. Antimicrob Agents Chemother. 2020. PMID: 33077652 Free PMC article.

Cite

Share

5

Cite

Share

Diosgenin Suppresses Cholangiocarcinoma Cells Via Inducing Cell Cycle Arrest And Mitochondria-Mediated Apoptosis.

Mao XM, Zhou P, Li SY, Zhang XY, Shen JX, Chen QX, Zhuang JX, Shen DY. Mao XM, et al. Onco Targets Ther. 2019 Nov 4;12:9093-9104. doi: 10.2147/OTT.S226261. eCollection 2019. Onco Targets Ther. 2019. PMID: 31806994 Free PMC article.

Cite

Share

6

Cite

Share

Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of Tuberculosis.

Bigelow KM, Deitchman AN, Li SY, Barnes-Boyle K, Tyagi S, Soni H, Dooley KE, Savic RM, Nuermberger EL. Bigelow KM, et al. J Infect Dis. 2021 Jun 4;223(11):1855-1864. doi: 10.1093/infdis/jiaa016. J Infect Dis. 2021. PMID: 31993638 Free PMC article.

Cite

Share

7

Cite

Share

Pooled-matrix protein interaction screens using Barcode Fusion Genetics.

Yachie N, Petsalaki E, Mellor JC, Weile J, Jacob Y, Verby M, Ozturk SB, Li S, Cote AG, Mosca R, Knapp JJ, Ko M, Yu A, Gebbia M, Sahni N, Yi S, Tyagi T, Sheykhkarimli D, Roth JF, Wong C, Musa L, Snider J, Liu YC, Yu H, Braun P, Stagljar I, Hao T, Calderwood MA, Pelletier L, Aloy P, Hill DE, Vidal M, Roth FP. Yachie N, et al. Among authors: li s. Mol Syst Biol. 2016 Apr 22;12(4):863. doi: 10.15252/msb.20156660. Mol Syst Biol. 2016. PMID: 27107012 Free PMC article.

Cite

Share

8

Cite

Share

High-Dose Rifamycins Enable Shorter Oral Treatment in a Murine Model of Mycobacterium ulcerans Disease.

Omansen TF, Almeida D, Converse PJ, Li SY, Lee J, Stienstra Y, van der Werf T, Grosset JH, Nuermberger EL. Omansen TF, et al. Antimicrob Agents Chemother. 2019 Jan 29;63(2):e01478-18. doi: 10.1128/AAC.01478-18. Print 2019 Feb. Antimicrob Agents Chemother. 2019. PMID: 30455239 Free PMC article.

Cite

Share

9

Cite

Share

Nuclear translocation of the 4-pass transmembrane protein Tspan8.

Huang Y, Li J, Du W, Li S, Li Y, Qu H, Xv J, Yu L, Zhu R, Wang H. Huang Y, et al. Among authors: li s. Cell Res. 2021 Nov;31(11):1218-1221. doi: 10.1038/s41422-021-00522-9. Epub 2021 Jun 7. Cell Res. 2021. PMID: 34099887 Free PMC article. No abstract available.

Cite

Share

10

Cite

Share

Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer.

Almeida DV, Omansen TF, Li SY, Lee J, Grosset JH, Converse PJ, Nuermberger EL. Almeida DV, et al. Antimicrob Agents Chemother. 2019 Feb 26;63(3):e02171-18. doi: 10.1128/AAC.02171-18. Print 2019 Mar. Antimicrob Agents Chemother. 2019. PMID: 30559131 Free PMC article.

Cite

Share